Blastoid mantle cell lymphoma: Evidence for nonrandom cytogenetic abnormalities additional to t(11;14) and generation of a mouse model

R. M'kacher, F. Farace, A. Bennaceur-Griscelli, D. Violot, B. Clausse, J. Dossou, A. Valent, C. Parmentier, V. Ribrag, J. Bosq, P. Carde, A. G. Turhan, A. Bernheim

    Résultats de recherche: Contribution à un journalArticleRevue par des pairs

    32 Citations (Scopus)

    Résumé

    Mantle cell lymphoma (MCL) is characterized by the t(11;14)(q13;q32), which is associated with cyclin D1 hyperexpression and a poor prognosis. MCL cases have been shown to progress to a more aggressive disease but the molecular events responsible of this phenomenon have not been determined. We have established two cell lines from the pleural effusions of two patients with MCL that we have used for further cytogenetic characterization to better define the incidence and nature of secondary chromosome abnormalities using multicolor fluorescence in situ hybridization, whole chromosome paint, and specific probes. Both cell lines grew independently without growth factors. Using CCND1/IGH-specific probes, patient UPN1 was found to have a masked t(11;14). Numerous and complex chromosomal abnormalities were found in both cell lines affecting chromosomes 2, 8, 13, 18, 22, X, and Y. These abnormalities included 8p losses, suggesting the presence of an anti-oncogene in this region, rearrangements of 8q24, MYC gene, and translocations involving 8, X, and Y chromosomes, which might be significant in the pathogenesis of MCL progression. The use of the cell lines (UPN1) allowed us to generate a mouse model of human MCL, mimicking a disseminated lymphoma and leading to the death of the animals in 4 weeks. This blastoid MCL model could be of major interest to determine molecular events involved in MCL progression, allowing isolation of involved genes and their functional characterization, and to study the effects of new chemotherapy regimens in mouse models.

    langue originaleAnglais
    Pages (de - à)32-38
    Nombre de pages7
    journalCancer Genetics and Cytogenetics
    Volume143
    Numéro de publication1
    Les DOIs
    étatPublié - 1 janv. 2003

    Contient cette citation